GitLab

GTLB · NASDAQ

$54.99+$1.70 (+3.19%)TodayMarket closed ·
Prev close $53.29

GTLB analyst rating

HoldConsensus of 29 analysts over the last 12 months. 24% rate it a buy.
  • Strong buy0
  • Buy7
  • Hold21
  • Underperform1
  • Sell0

12-month price target · 28 analysts

Average $55.45 (+0.8% upside)

Low
$35.35
Now
$54.99
High
$73.50

Upgrades and downgrades

The latest rating actions, newest first

GTLB analyst upgrades, downgrades and rating actions
FirmDateActionRating
William BlairSep 2, 2026UpgradeUnderperform → Market Perform
DA DavidsonSep 2, 2026MaintainsNeutral
Canaccord GenuitySep 2, 2026MaintainsBuy
Truist SecuritiesSep 2, 2026MaintainsHold
MacquarieSep 2, 2026MaintainsNeutral
Wells FargoSep 2, 2026MaintainsEqual-Weight
UBSSep 2, 2026MaintainsNeutral
MizuhoSep 2, 2026MaintainsNeutral
BarclaysSep 2, 2026MaintainsUnderweight
RBC CapitalSep 2, 2026MaintainsSector Perform

The case for and against

Updated Oct 14, 2026

Bull case

GitLab is well positioned because its unified, all-in-one DevSecOps platform spans the full software lifecycle, giving it a structural advantage over stitched-together point solutions and supporting greater budget authority in a ~$40B target market. Its growth outlook is improving as F1Q27 showed 30% y/y new logo growth, stronger win rates, and early traction for GitLab Duo Agent Platform, while management’s Act 2 investments in global go-to-market capacity should increasingly convert into bookings and cRPO. The company also benefits from AI-driven platform engagement, new products like GitLab Orbit and Governance for Agents, and customer demand for secure, sovereign, and compliant deployments across self-managed and SaaS models.

Bear case

GitLab is facing a deteriorating fundamental backdrop as DBNRR has declined for nine consecutive quarters, new logo acquisition is difficult in a saturated DevSecOps market, and tech layoffs are pressuring seat growth and customer caution. F2Q27 guidance for roughly 15-16% revenue growth implies meaningful deceleration from 23% in F1Q27, while prior upside from $2M of overages and early renewals, as well as the April 2023 price increase, is expected to fade in FY27; public sector visibility remains limited and the price-sensitive cohort is under strain. Act 2 adds execution risk through a 14% RIF and $30M-$35M of restructuring charges, while competition from Microsoft/GitHub and emerging alternatives, plus softening underlying billings and RPO trends, suggests durability concerns outweigh the company’s innovation narrative.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.